Sign in
Explore the registryTrack Aln-ang3's trials

A First In Human (FIH) Study to Learn if Different Doses of ALN-ANG3 Are Safe and Well Tolerated in Healthy Adults

ALN-ANG3OngoingActive not recruitingPhase 1Open NCT06452771 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…